ANI Pharmaceuticals Overview

  • Founded
  • 1996

Founded
  • Status
  • Public

  • Employees
  • 601

Employees
  • Stock Symbol
  • ANIP

Stock Symbol
  • Investments
  • 25

  • Share Price
  • $35.84

  • (As of Thursday Closing)

ANI Pharmaceuticals General Information

Description

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Stock Exchange
NAS
Primary Office
  • 210 Main Street West
  • Baudette, MN 56623
  • United States
+1 (218) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ANI Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$35.84 $35.87 $22.31 - $60.23 $625M 17.4M 97.6K -$4.30

ANI Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 746,487 958,187 528,619 871,921
Revenue 251,322 216,136 208,475 206,547
EBITDA (8,718) 3,164 28,190 60,735
Net Income (63,636) (42,603) (22,548) 6,094
Total Assets 751,334 771,598 461,190 456,789
Total Debt 286,945 287,370 185,686 185,749
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ANI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ANI Pharmaceuticals‘s full profile, request access.

Request a free trial

ANI Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid
Pharmaceuticals
Baudette, MN
601 As of 2021
00000
000000000 00000

0000 0

do consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
000000000000000
Haifa Bay, Israel
0000 As of 0000
0000
0.000 0000-00-00
00000000000

000000

lor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magn
000000000000000
Trevose, PA
000 As of 0000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ANI Pharmaceuticals Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taro Pharmaceutical Industries Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
0000000 0000000 Corporation Trevose, PA 000 000000000
000000000000000 00 Corporation Lagos, Nigeria 00
000000 00000000000 Formerly PE-Backed Bridgewater, NJ 0000 00.000 000000 - 000 00.000
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0000000000.
You’re viewing 5 of 12 competitors. Get the full list »

ANI Pharmaceuticals Patents

ANI Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120046264-A1 Commercial scale production methods for transdermal hormone formulations Abandoned 17-Aug-2010 0000000000
US-20170232002-A1 Commercial scale production methods for transdermal hormone formulations Abandoned 17-Aug-2010 0000000000
US-20120022033-A1 Methods for decreasing cardiovascular risk in postmenopausal women Abandoned 23-Jul-2010 0000000000
US-20170128462-A1 Methods for treating female sexual dysfunction while decreasing cardiovascular risk Abandoned 02-Jul-2010 0000000000
US-20120004204-A1 Methods for treating sexual dysfunction while decreasing cardiovascular risk Abandoned 02-Jul-2010 A61K31/568
To view ANI Pharmaceuticals’s complete patent history, request access »

ANI Pharmaceuticals Executive Team (17)

Name Title Board Seat Contact Info
Nikhil Lalwani Chief Executive Officer & Board Member
Stephen Carey Senior Vice President and Chief Financial Officer
Muthusamy Shanmugam Chief Operating Officer, Operations & Board Member
Christopher Mutz Executive
Brian McCrudden Senior Director of Business Development
You’re viewing 5 of 17 executive team members. Get the full list »

ANI Pharmaceuticals Board Members (11)

Name Representing Role Since
0000000 0000 ANI Pharmaceuticals Board Member 000 0000
00000 0000 00 Self Board Member 000 0000
000000 00000 ANI Pharmaceuticals Board Member 000 0000
000000000 000000000 ANI Pharmaceuticals Chief Operating Officer, Operations & Board Member 000 0000
000000 0000000 ANI Pharmaceuticals Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

ANI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ANI Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ANI Pharmaceuticals‘s full profile, request access.

Request a free trial

ANI Pharmaceuticals Investments & Acquisitions (25)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 28-Jun-2022 000000000 Buildings and Property 000000 00
00000000 0000 19-Nov-2021 0000000000 00000 Pharmaceuticals 000000 00
000000 (0 000 06-Apr-2021 000000000 Buildings and Property 000000 00
000 000000000 01-Jul-2020 000000000 000 Buildings and Property
Amerigen Pharmaceuticals 09-Jan-2020 Merger/Acquisition 000.00 Pharmaceuticals 000000 00
You’re viewing 5 of 25 investments and acquisitions. Get the full list »

ANI Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000 Pharmaceuticals East Windsor, NJ 0000
To view ANI Pharmaceuticals’s complete subsidiaries history, request access »